Į pradžią Mokslas VUOI
El.paštas Į Vėžio registrą
Svetainės žemėlapis
Spausdinti
 
Lietuviškai English
Registracija INTERNETU
Registracija telefonu ir informacija
Struktūra ir kontaktai
Direktorius
Taryba
Struktūra
Kontaktai
Veikla
Istorija
Veiklos dokumentai
Etikos komisija
Veiklos tikslai
Ataskaitos
Klinika
Klinikiniai tyrimai
Mokslas
Mokymas
Prevencija ir apskaita
Paslaugos
Viešieji pirkimai
Europos parama
NVI Europos erdvėje
Narystė ES organizacijose
Dalyvavimas ES projektuose
Naujienos
Leidyba
Onkologo puslapiai
Acta medica Lituanica
Lietuvos chirurgija /Lithuanian Surgery
Draugijos
Galerija
Nuorodos
Padėkos
Skelbimai
Prisijungimo vardas: 
Slaptažodis: 




 

 

 

 

Informacija pacientams Paslaugos Vėžio registras
Publications

BOOKLET

  1. Institute of Oncology, Vilnius University SCIENTIFIC RESEARCH CENTER, 2009

PUBLICATIONS 2010 in ISI Master Journal

  1. Akramienė D, Aleksandravičienė Č, Graželienė G, Žalinkevičius R, Sužiedėlis K, Didžiapetrienė J, Simonsen U, Stankevičius E, Kėvelaitis E. Potentiating effect of beta-glucans on photodynamic therapy of implanted cancer cells in mice. Tohoku J Exp Med. 2010; 220(4):299–306.
  2. Arbyn M, Antoine J, Valerianova Z, Magi M, Stengrevics A, Smailyte G, Suteu O, Micheli A. Trends in cervical cancer incidence and mortality in Bulgaria, Estonia, Latvia and Romania. Tumori. 2010; 96:517–523.
  3. Asadauskienė J, Aleknavičius E, Pipirienė-Želvienė T, Jankevičius F. The value of clinical prognostic factors for survival in patients with invasive urinary bladder cancer. Medicina. 2010; 46(5):305–314.
  4. Baranauskas Z, Valuckas KP, Tiškevičius S. Outcomes of long-term combined treatment in follicular thyroid carcinoma. Medicina. 2010; 46(4):268–274.
  5. Baranauskas Z, Valuckas KP, Smailytė G. Combined treatment and survival of medullary thyroid carcinoma patients. Centr Eur J Med. 2010; 5(4):426–430.
  6. Cappuzzo F, Ciuleanu T, Stelmakh L, Cicėnas S, Szczesna A, Juhasz E, Esteban E, Molinier O, Brugger W, Melizinek I, Klingelschmitt G, Klughammer B, Giaccone G. Erlotinib as maintenance treatment in advanced non-small cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study. Lancet Oncol. 2010; 11(6):521–529.
  7. Cicėnas S, Kurtinaitis J, Smailytė G. Outcome and treatment strategy in female lung cancer: a single institution experience. Adv Med Sci. 2010; 30;55(2):273–280.
  8. Dabkevičienė D, Stankevičius V, Graželienė G, Markuckas A, Didžiapetrienė J, Kirvelienė V. mTHPC-mediated photodynamic treatment of Lewis lung carcinoma in vitro and in vivo. Medicina. 2010; 46(5):345–350.
  9. Domža G, Gudlevičienė Z, Didžiapetrienė J, Valuckas KP, Kazbarienė B, Drąsutienė G. Human papillomavirus infection in pregnant women. Arch Gynecol Obstet. 2010 Dec 18. [Epub ahead of print].
  10. Elsakov P, Kurtinaitis J, Petraitis S, Ostapenko V, Razumas M, Razumas T, Meskauskas R, Petrulis K, Lukšytė A, Lubinski J, Gorski B, Narod SA, Gronwald J. The contribution of founder mutations in BRCA1 to breast and ovarian cancer in Lithuania. Clin Genet. 2010; 78(4):373–376.
  11. Gleiznienė R, Bučinskas U, Lukoševičius S, Vaitkus A, Letautienė SR, Apanavičiūtė D, Galvonaitė M. Gliomatosis cerebri. Medicina. 2010; 46(5):341–344.

  12. Gudlevičienė Ž, Šepetienė A, Didžiapetrienė J, Valuckas KP, Smailytė G, Drąsutienė G, Nadišauskienė RJ. Infekuotumas atskirų žmogaus papilomos tipų virusais esant intraepitelinių gimdos kaklelio pokyčių. Medicina. 2010; 46(9):616–623.

  13. Heiss MM, Murawa P, Koralewski P, Kutarska E, Kolesnik OO, Ivanchenko VV, Dudnichenko AS, Aleknaviciene B, Razbadauskas A, Gore M, Ganea-Motan E, Ciuleanu T, Wimberger P, Schmittel A, Schmalfeldt B, Burges A, Bokemeyer C, Lindhofer H, Lahr A, Parsons SL. The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: results of a prospective randomized phase II/III trial. Int J Cancer. 2010; 127(9):2209–2221.

  14. Inciura A, Atkocius V, Juozaityte E, Vaitkiene D. Long-term results of high-dose-rate brachytherapy and external-beam radiotherapy in the primary treatment of endometrial cancer. J Radiat Res. 2010; 51(6):675–681.

  15. Jackevičius A, Mudėnas A, Šarakauskienė L, Ostapenko V, Bružas S, Jovaišienė V. The follow-up results of treatment of male breast carcinoma. EJC Suppl. 2010; 8(3): 136.

  16. Jarmalaitė S, Laurinavičienė A, Tverkuvienė J, Daniūnaitė K, Ščėsnaitė A, Ostapenko V, Lazutka J. Identification of prognostic molecular biomarkers in early-stage breast cancer. Conference Information: Congress of the International-Society-for-Cellular-Oncology, Mar 17-19, 2010 Dresden, Germany. Cell Oncol. 2010; 32(3):223.

  17. Jarmalaitė S, Andrėkutė R, Ščėsnaitė A, Sužiedėlis K, Husgafvel-Pursiainen K, Jankevičius F. Promoter hypermethylation in tumour suppressor genes and response to interleukin-2 treatment in bladder cancer: a pilot study. J Cancer Res Clin Oncol. 2010; 136(6):847–854.

  18. Kuzmickienė I, Stukonis M. Cancer incidence among women flax textile manufacturing workers in Lithuania. Occup Environ Med. 2010; 67(7):500–502.

  19. Lotan Y, Shariat SF, Schmitz-Drager BJ, Sanchez-Carbayo M, Jankevičius F, Racioppi M, Minner SJP, Stohr B, Bassi PF, Grossman HB. Considerations on implementing diagnostic markers into clinical decision making in bladder cancer. Urol Oncol. 2010; 28(4):441–448.

  20. Ridgway D, Sopata M, Burneckis A, Jespersen L, Andersen C. Clinical efficacy and safety of once-daily dosing of a novel, prolonged-release oral morphine tablet compared with twice daily dosing of a standart controlled-release morphine tablet in patients with cancer pain: a randomized, double-blind, exploratory crossover study. J Pain Symptom Manage. 2010; 39(4):712–720.

  21. Rosso S, Gondos A, Zanetti R, Bray F, Zakelj M, Zagar T, Smailyte G, Ponti A, Brewster DH, Voogd AC, Crocetti E, Brenner H; EUNICE Survival Working Group. Up-to-date estimates of breast cancer survival for the years 2000-2004 in 11 European countries: the role of screening and a comparison with data from the United States. Eur J Cancer. 2010; 46(18):3351–3357.

  22. Sjakste N, Bagdoniene L, Gutcaits A, Labeikyte D, Bielskiene K, Trapina I, Muiznieks I, Vassetzky Y, Sjakste T. Proteins tightly bound to DNA: new data and old problems. biochemistry (Mosc). 2010; 75(10):1240–1251.

  23. Stakišaitis D, Dudėnienė G, Jankūnas RJ, Graželienė G, Didžiapetrienė J, Pundzienė B. Cisplatin increases urinary sodium excretion in rats: gender-related differences. Medicina. 2010; 46(1):45–50.

  24. Strioga M, Characiejus D, Gibavičienė J, Pašukonienė V, Petraitis T. Two-faced antitumor immunity. Exp. Oncol. 2010; 32 (Suppl.): 22–30.

  25. Šeputienė V, Povilonis J, Armalytė J, Sužiedėlis K, Pavilonis A, Sužiedėlienė E. Tigecycline – how powerful is it in the fight against antibiotic-resistant bacteria? Medicina. 2010; 46(4):240–248.

PUBLICATIONS 2011 in ISI Master Journal

  1. Arbyn M, Antoine J, Maegi M, Smailytė G, Stengrevics A, Şuteu O, Valerianova Z, Bray F, Weiderpass E. Trends in cervical cancer incidence and mortality in the Baltic countries. Bulgaria and Romania. Inter J Cancer. 2011; 128(8): 1899–1907.
  2. Bulotienė G, Žalnierūnaitė L. Psychological distress in Lithuanian women with breast cancer. Revista Argentina de Clínica Psicológica. 2011; XX(3): 271–278.
  3. Burn J, Bishop DT, Chapman PD, Elliott F, Bertario L, Dunlop MG, Eccles D, Ellis A, Evans DG, Fodde R, Maher ER, Möslein G, Vasen HF, Coaker J, Phillips RK, Bülow S, Mathers JC, Haites N, Lunt P, Koch J, Turner G, Trembath R, Lalloo F, Quarrell O, Murday V, Lenaerts C, Cze J, Fidalgo P, Alonso A, Tempesta A, Lubinski J, Akerbrant H, Hultcrantz R, Samalavičius NE, Hurlin Cummings J, Armstrong O, Reed L, Dixon B, Thomas L. A randomized placebo-controlled prevention trial of aspirin and/or resistant starch in young people with familial adenomatous polyposis. Cancer Prev Res. 2011; 4(5): 655–665.
  4. Characiejus D, Pašukonienė V, Jacobs John JL., Eidukevičius R, Jankevičius F, Dobrovolskienė N, Mauricas M, Moorselaar R, Jeroen A. van Otter, Willem D. Prognostic significance of peripheral blood CD8(high)CD57+ lymphocytes in bladder carcinoma patients after intravesical IL-2. Anticancer Res. 2011; 31(2): 699–703.
  5. Characiejus D, Jacobs John JL, Pašukonienė V, Kazlauskaitė N, Danilevičiūtė V, Mauricas M, Otter WD. Prediction of response in cancer immunotherapy. Anticancer Res. 2011; 31(2): 639–647.
  6. Didžiapetrienė J, Kanopienė D, Valuckas KP, Uleckienė S, Atkočius V, Mickė I, Sužiedėlis K. Microsatellite instability and loss of heterozygosity in cancer. Medicina. 2011; 47(2): 125–135.
  7. Domza G, Gudleviciene Z, Didziapetriene J, Valuckas KP, Kazbariene B, Drasutiene G. Human papillomavirus infection in pregnant women. Arch Gynecol Obstet. 2011; 284(5): 1105–1112.
  8. Drižienė Ž, Jankūnas R, Stakišaitis D, Kazbarienė B, Didžiapetrienė J, Uleckienė S. Urinary chloride: gender-related differences and relation to blood pressure in adolescents. Trace Elem & Electrol. 2011; 28(2): 105–112.
  9. Drobnienė M, Cicėnienė A, Pipirienė Želvienė T, Grigienė R, Lachej N, Steponavičienė L, Aleknavičius E. Targeted Therapy in Patients With Non-small Cell Lung Cancer Previously Treated with Chemotherapy. Medicina. 2011; 47(9): 520–525.
  10. Jagminas A, Kurtinaitienė M, Mažeika K, Rotomskis R, Niaura G, Selskis A. Fabrication and characterization of magnetic ferrofluids by the co-precipitation way using diglycolic acid. J Nanoparticle Res. 2011; 13(9): "4133–4142.
  11. Jarmalaitė S, Laurinavičienė A, Tverkuvienė J, Kalinauskaitė N, Petroška D, Böhling T, Husgafvel-Pursiainen K. Tumor suppressor gene ZAC/PLAGL1: altered expression and loss of the nonimprinted allele in pheochromocytomas. Cancer Genet. 2011; 204(7): 398–404.
  12. Juška A, Ulys A, Kairevičė L, Smailytė G, Stankevičius E, Jančiauskienė R, Jievaltas M. Survival of patients with testicular cancer in Lithuania during 1999–2002. Medicina. 2011; 47(1): 52–56.
  13. Kruis W, Jonaitis L, Pokrotnieks J, Mikhailova, TL, Horynski M, Batovsky M, Lozynsky, YS, Zakharash Y, Racz I, Kull K, Vcev A, Faszczyk M, Dilger K, Greinwald R, Mueller R and the International Salofalk OD study group (Samalavicius NE). Randomised clinical trial: a comparative dose-finding study of three arms of dual release mesalazine for maintaining remission in ulcerative colitis. Aliment Pharmacol Ther. 2011, 33:313-322.
  14. Kulvietis V, Streckytė G, Rotomskis R. Spectroscopic investigations of CdTe quantum dot stability in different aqueous media. Lithuanian Journal of Physics. 2011; 51(2): 163–171.
  15. Kulvietis V, Zalgeviciene V, Didziapetriene J, Rotomskis R. Transport of nanoparticles through the placental barrier. Tohoku J Exp Med. 2011: 225(4): 225–234.
  16. Kurita Geana P, Sjøgren P, Ekholm O, Kaasa S, Loge Jon H, Povilonienė I, Klepstad P, Prevalence and predictors of cognitive dysfunction in opioid-treated patients with cancer: a multinational study. J Clin Oncol. 2011; 29(10): 1297–1303.
  17. Laurinavicius A, Laurinaviciene A, Dasevicius D, Elie N, Plancoulaine B, Bor C, Herlin P. Digital image analysis in pathology: Benefits and obligation. Anal Cell Pathol. 2011; 34: 1–4.
  18. Laurinaviciene A, Dasevicius D, Ostapenko V, Jarmalaite S, Lazutka J, Laurinavicius A. Membrane connectivity estimated by digital image analysis of HER2 immunohistochemistry is concordant with visual scoring and fluorescence in situ hybridization results: algorithm evaluation on breast cancer tissue microarrays. Diagn Pathol. 2011; 6(87): 2–10.
  19. Moncevičiūtė-Eringienė E. The evolutionary atavistic endotoxin and neoplastic growth. Med Hypotheses. 2011; 76: 128–131.
  20. Petrauskaitė-Everatt R, Kuzmickienė I, Senulis A. Cigarette smoking and trends in lung cancer incidence in Lithuania: an analysis by histological type. Medicina. 2011; 47(4): 222–229.
  21. Poderys V, Matulionytė M, Selskis A, Rotomskis R. Interaction of water-soluble CdTe quantum dots with bovine serum albumin. Nanoscale Res Lett. 2011; 6: 9.
  22. Rugienė R, Dadonienė J, Aleknavičius E, Tikuišis R, Distler J, Schett G, Venalis P, Venalis A. Prevalence of paraneoplastic rheumatic syndromes and their antibody profile among patients with solid tumours. Clin Rheumatol. 2011; 30(3): 373–380.
  23. Šepetienė A, Gudlevičienė Ž, Bumbulienė Ž, Drąsutienė GS, Didžiapetrienė J. State of HPV16 integration in Lithuanian women with cervical neoplasia. Centr Eur J Med. 2011; 6(2): 205–212.
  24. Šilėnas A, Miller A, Požela J, Požela K, Dapkus L, Jucienė V. Graded-gap AlxGa1-xAs detector for high-energy electron beam dosimetry. Nuclear instruments & methods in physics research. A. 2011; 633(suppl. 1): S62–S64.
  25. Slapšytė G, Mierauskienė J, Uleckienė S, Didžiapetrienė J. Modifying effect of vitamin E and ethanol on benzo[a]pyrene induced chromosome damage in mice bone marrow cells. Veterinarija ir zootechnika. 2011; 53(75): 56–60.
  26. Smailytė G, Averkin Y, Veyalkin I, Krasny S, Ulinskas K. Comparison of prostate cancer patient’s survival in Belarus and Lithuania. Centr Euro J Med. 2011; 6(5): 545–549.
  27. Stakisaitis D, Driziene Z, Uleckiene S, Kazbariene B, Didziapetriene J. Gender-related differences of urinary magnesium excretion: implications for chemotherapy in cancer patients. Trace Elem & Electrol. 2011; 24(4): 208–212.
  28. Steponaviciene L, Lachej-Mikeroviene N, Smailyte G, Aleknavicius E, Meskauskas R, Didziapetriene J. Triple negative breast cancer: adjuvant chemotherapy effect on survival. Adv Med Sci. 2011; 23: 1–6.
  29. Steponkiene S, Kavaliauskiene S, Purviniene R, Rotomskis R, Juzenas P. Quantum dots affect expression of CD133 surface antigen in melanoma cells. Int J Nanomedicine. 2011; 6: 2437–2444.
  30. Strioga M, Pasukoniene V, Characiejus D. CD8(+) CD28(-) and CD8(+) CD57 (+) T cells and their role in health and disease. Immunology. 2011; 134(1): 17–32.
  31. Žalgevičienė V, Graželienė G, Žukienė J, Didžiapetrienė J. The effect of β-carotene against adriamycin toxicity on the embryo formation. Medicina. 2011; 47(1): 46–51.
  32. Vasiliauskas A, Leonaviciene L, Bradunaite R, Vaitkiene D, Luksiene A. Investigation of Aesculus hippocastanum L tincture on the content of trace elements and pro-/antioxidant status of organism in rats with adjuvant arthritis. Trace Elem & Electrol. 2011; 28(4): 199–207.
  33. Venius J; Bagdonas S, Zurauskas E, Rotomskis R. Visualization of human heart conduction system by means of fluorescence spectroscopy. J Biomed Opt. 2011; 16(10):107001.
  34. Venius J, Bagdonas S, Žurauskas E, Rotomskis R. Time-resolved fluorescence spectroscopy of the heart tissues. Lithuanian Journal of Physics. 2011; 51(4): 317–323.

 

 

PUBLICATIONS 2010 in international journals

  1. Averkin YI, Smailyte G, Misinsh Y, Leya M. The formation, development and improvement of registration and dispensary system for cancer patients as the basis for organization and evaluation of cancer contol efficacy in Belarus, Lithuania and Latvia [in russ.]. Oncol J; 2010; 15(3):92–99.
  2. Jakubovskij E, Griskevicius R, Miller A. IMRT commissioning: Baltic institutions planning and dosimetry comparisons. Medical Physics in the Baltic States: proceedings of the 8th international conference on medical physics; Kaunas, Lithuania. 2010; 2:11–13.
  3. Kišonas J, Kulvietis V. Spectroscopic study of quantum dots distribution in vivo. Medical Physics in the Baltic States: proceedings of the 8th international conference on medical physics; Kaunas, Lithuania. 2010; 2:54–58.
  4. Kulvietis V, Rotomskis R. Accumulation of quantum dots in Ehrlich ascites tumour in mice. Medical Physics in the Baltic States: proceedings of the 8th international conference on medical physics; Kaunas, Lithuania. 2010; 2:50–53.
  5. Manegold C, Cicenas S, Eschbach C, Kollmeier J, Kortsik C, Schumann C, Serke M, Steins M, Pilz L. R. The EGFR-targeting chimeric monoclonal IgG-1 antibody cetuximab (CTX) added either to gemcitabine (G) followed by docetaxel (D) or carboplatin/gemcitabine (CP/G) in chemonaïve patients (pts) with advanced non-small cell lung cancer (NSCLC): Preliminary safety results of the ongoing GemTax IV trial. J Clin Oncol. 2010; 28 (Suppl 15): e18010.
  6. Matulionytė M, Poderys V, Rotomskis R. Influence of surface coating on cdte quantum dots stability and interaction with bovine serum albumin. Medical Physics in the Baltic States: proceedings of the 8th international conference on medical physics; Kaunas, Lithuania. 2010; 2:67–70.
  7. Miller A, Kasiulaitytė L. IMRT for craniospinal irradiation: challenges and results. Medical Physics in the Baltic States: proceedings of the 8th international conference on medical physics; Kaunas, Lithuania. 2010; 2:7–10.
  8. Petrošiūtė S, Purvinienė R, Pašukonienė V, Lukoševičiūtė S, Juzėnas P, Rotomskis R. Characterization of cancer stem cells and their response to CdTe quantum dots. Medical Physics in the Baltic States: proceedings of the 8th international conference on medical physics; Kaunas, Lithuania. 2010; 2:71–76.
  9. Poderys V, Selskis A, Ilie A, Rotomskis R. Ring like Tpps4 J-aggregate structure. Medical Physics in the Baltic States: proceedings of the 8th international conference on medical physics; Kaunas, Lithuania. 2010; 2:62–66.
  10. Rimiene J, Petronyte J, Gudleviciene Z, Smailyte G, Krasauskaite I, Laurinavicius A. A Shandon PapSpin liquid-based gynecological test: A split-sample and direct-to-vial test with histology follow-up study. CytoJournal. 2010; 7:2.
  11. Skripka A, Valančiūnaitė J, Rotomskis R. Spectral study on the formation of quantum dots and chlorin E6 complex in the presence of protein. Medical Physics in the Baltic States: proceedings of the 8th international conference on medical physics; Kaunas, Lithuania. 2010; 2:59–61.
  12. Stašys K, Karabanovas V, Rotomskis R, Valius M. Surface modification of (CdSe) ZnS quantum dots using thiols – characterization, photophysical and biological studies. Medical Physics in the Baltic States: proceedings of the 8th international conference on medical physics; Kaunas, Lithuania. 2010, 2:77–81.
  13. Valančiūnaitė J, Rotomskis R. Quantum dots as energy donors for photodynamic therapy of cancer. Medical Physics in the Baltic States: proceedings of the 8th international conference on medical physics; Kaunas, Lithuania. 2010; 2:44–49.
  14. Jacobs JJL, Characiejus D, Pašukonienė V, Jankevičius F, Van Moorselaar RJA, Mauricas M, Den Otter W. Recurrences of superficial bladder carcinoma are associated with a raise of CD8highCD57+ and CD8low T lymphocytes in peripheral blood. The Open Cancer Immunology Journal. 2010; 3: 8–14.

 

 

PUBLICATIONS 2011 in international journals

  1. Ivanauskas A, Aleknavičius E, Burneckis A, Miller A. Dosimetric options and possibilities of prostate LDR brachytherapy with permanent I-125 implants. Medical Physics in the Baltic States 9. Kaunas, Lithuania. 2011; 98–101.
  2. Kubiliūtė R, Šlėktaitė A, Burkanas M, Grigienė R, Rotomskis R. Gold nanoparticles as a contrast agent for X-ray imaging. Medical Physics in the Baltic States 9. Kaunas, Lithuania. 2011; 27–30.
  3. Kulvietis V, Žalgevičienė V, Didžiapetrienė J, Bulotienė D, Rotomskis R. Distribution of nanoparticles in the pregnant rat: the morphologic and spectroscopic study. Papers on Anthropology. 2011; 20: 218–228.
  4. Kuzmickienė I, Aleknavičius E, Valuckas KP, Ostapenko V, Atkočius V, Burneckis A. Incidence of cardiovascular disease following breast radiation therapy. Medical Physics in the Baltic States 9. Kaunas, Lithuania. 2011; 57–60.
  5. Nevulis-Obuchovska V, Jakubovskij E, Miller A. Radiotherapy treatment planning methods comparison for pediatric retroperitoneal tumors: case report. Medical Physics in the Baltic States 9. Kaunas, Lithuania. 2011; 102–106.
  6. Samalavičius NE, Kilius A, Petrulis K. Transanal endoscopic microsurgery: a single centre experience. The Sri Lankan Journal of Surgery. 2011, 29(1):19–22.
  7. Šileika E, Aleknavičius E, Burneckis A, Jakubovskij E, Ivanauskas A. Retrospective analysis of treatment management of patients with glioblastoma in Oncology institute of Vilnius University. Medical Physics in the Baltic States 9. Kaunas, Lithuania. 2011; 61–64.
  8. Ulys A, Samalavicius NE, Cicenas S, Petraitis T, Trakymas M, Sheinin D, Gatijatullin L. Case report: Extralobar pulmonary sequestration. International Medical Case Reports Journal. 2011; 4: 21–23.
  9. Ostapenko V. The value and characteristics of surgical treatment of locally advanced breast cancer. Voprosy onkologii. 2011; 9:578–584.

Į viršų
VU Onkologijos instituto herbas

Nacionalinis vėžio institutas

Santariškių g., 1
LT-08660
Vilnius
Faksas (8 5) 272 0164

Registracija (8.00-15.30):
(8 5) 278 6711
(8 5) 278 6712
(8 5) 278 6715 

Registracija pagal programas
(8.00-15.30)
(8-5) 219 0966

Registracija mokamais skambučiais
(kaina 1,5 lt x1 min.)
1815

Įmonės kodas: 111959420
PVM mokėtojo kodas: LT119594219

Paramos lėšų  sąskaitos Nr.
LT85 7044 0600 0616 2336
AB SEB bankas, banko kodas 70440

Atstovė spaudai
tel.: (8 5) 278 6733
el.paštas:
juventa.sartatavicienenvi.lt

Praneškite mums apie aptiktas klaidas, teikite pastabas, pasiūlymus. Spauskite čia !

Lankytojų statistika

Nuo: 2007-01-19
Iš viso: 3462322
Šiandien: 742
Dabar: 13

Visa  svetainėje www.vuoi.lt paskelbta informacija yra intelektinė VU Onkologijos instituto nuosavybė.
Draudžiama be raštiško leidimo naudoti ir platinti grafinę bei tekstinę informaciją žiniasklaidos priemonėse bei kitose interneto svetainėse.

© 2010 Vilniaus universiteto Onkologijos institutas.

 

 

 

Sprendimas: Idamas